{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:24:43Z","timestamp":1774056283884,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Temperature control is recommended after out of hospital cardiac arrest (OHCA) by international guidelines. This survey aimed to investigate current clinical practice and areas of uncertainty.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Online survey targeting members of three medical emergency and critical care societies in Germany (April 21\u2013June 6, 2022) assessing post-cardiac arrest temperature control management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 341 completed questionnaires 28% (<jats:italic>n<\/jats:italic>\u2009=\u200997) used temperature control with normothermic target and 72% (<jats:italic>n<\/jats:italic>\u2009=\u2009244) temperature control with hypothermic target. The definition of fever regarding patients with cardiac arrest ranged from\u2009\u2265\u200937.7 to 39.0\u00a0\u00b0C. Temperature control was mainly started in the ICU (80%, <jats:italic>n<\/jats:italic>\u2009=\u2009273) and most commonly core cooling (74%, <jats:italic>n<\/jats:italic>\u2009=\u2009254) and surface cooling (39%, <jats:italic>n<\/jats:italic>\u2009=\u2009134) with feedback\u00a0were used. Temperature control was maintained for 24\u00a0h in 18% (<jats:italic>n<\/jats:italic>\u2009=\u200961), 48\u00a0h in 28% (<jats:italic>n<\/jats:italic>\u2009=\u200994), 72\u00a0h in 42% (<jats:italic>n<\/jats:italic>\u2009=\u2009143) and longer than 72\u00a0h in 13% (<jats:italic>n<\/jats:italic>\u2009=\u200943). 7% (n\u2009=\u200924) were using different protocols for OHCA with initial shockable and non-shockable rhythm. Additional 14% (<jats:italic>n<\/jats:italic>\u2009=\u200948) were using different temperature control protocols after in-hospital cardiac arrest (IHCA) compared with OHCA. Overall, 37% (<jats:italic>n<\/jats:italic>\u2009=\u2009127) changed practice after the publication of the ERC-2021 guidelines and 33% (<jats:italic>n<\/jats:italic>\u2009=\u2009114) after the recent publication of the revised ERC-ESICM guideline on temperature control.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>One-third of the respondents changed clinical practice since recent guideline update. However, a majority of physicians further trusts in temperature control with a hypothermic target. Of interest, 14% used different temperature control strategies after IHCA compared with OHCA and 7% for shockable and non-shockable initial rhythm. A more individualized approach in post resuscitation care may be warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-023-04319-7","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T11:03:03Z","timestamp":1674471783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Temperature control in adults after cardiac arrest: a survey of current clinical practice in Germany"],"prefix":"10.1186","volume":"27","author":[{"given":"Kevin","family":"Roedl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Wolfrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Michels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Pin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerold","family":"S\u00f6ffker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"issue":"11","key":"4319_CR1","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1007\/s00134-013-3043-4","volume":"39","author":"V Lemiale","year":"2013","unstructured":"Lemiale V, Dumas F, Mongardon N, Giovanetti O, Charpentier J, Chiche JD, Carli P, Mira JP, Nolan J, Cariou A. Intensive care unit mortality after cardiac arrest: the relative contribution of shock and brain injury in a large cohort. Intensive Care Med. 2013;39(11):1972\u201380.","journal-title":"Intensive Care Med"},{"issue":"8","key":"4319_CR2","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.resuscitation.2014.04.023","volume":"85","author":"C Storm","year":"2014","unstructured":"Storm C, Meyer T, Schroeder T, Wutzler A, Jorres A, Leithner C. Use of target temperature management after cardiac arrest in Germany: a nationwide survey including 951 intensive care units. Resuscitation. 2014;85(8):1012\u20137.","journal-title":"Resuscitation"},{"issue":"24","key":"4319_CR3","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa2100591","volume":"384","author":"J Dankiewicz","year":"2021","unstructured":"Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Levin H, Ullen S, Rylander C, Wise MP, Oddo M, Cariou A, et al. Hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med. 2021;384(24):2283\u201394.","journal-title":"N Engl J Med"},{"key":"4319_CR4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.122.060106","volume":"146","author":"S Wolfrum","year":"2022","unstructured":"Wolfrum S, Roedl K, Hanebutte A, Pfeifer R, Kurowski V, Riessen R, Daubmann A, Braune S, S\u00f6ffker G, Bibiza-Freiwald E, et al. Temperature control after in-hospital cardiac arrest: a randomized clinical trial. Circulation. 2022;146:1357\u201366.","journal-title":"Circulation"},{"issue":"3","key":"4319_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00134-022-06620-5","volume":"48","author":"C Sandroni","year":"2022","unstructured":"Sandroni C, Nolan JP, Andersen LW, Bottiger BW, Cariou A, Cronberg T, Friberg H, Genbrugge C, Lilja G, Morley PT, et al. ERC-ESICM guidelines on temperature control after cardiac arrest in adults. Intensive Care Med. 2022;48(3):261\u20139.","journal-title":"Intensive Care Med"},{"key":"4319_CR6","doi-asserted-by":"crossref","unstructured":"Nolan JP, Sandroni C, B\u00f6ttiger BW, Cariou A, Cronberg T, Friberg H, Genbrugge C, Haywood K, Lilja G, Moulaert VRM, et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care. Intensive Care Med. 2021;1\u201353.","DOI":"10.1016\/j.resuscitation.2021.02.012"},{"issue":"16","key":"4319_CR7","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1001\/archinte.161.16.2007","volume":"161","author":"A Zeiner","year":"2001","unstructured":"Zeiner A, Holzer M, Sterz F, Sch\u00f6rkhuber W, Eisenburger P, Havel C, Kliegel A, Laggner AN. Hyperthermia after cardiac arrest is associated with an unfavorable neurologic outcome. Arch Intern Med. 2001;161(16):2007\u201312.","journal-title":"Arch Intern Med"},{"issue":"3","key":"4319_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0300-9572(03)00184-9","volume":"57","author":"JP Nolan","year":"2003","unstructured":"Nolan JP, Morley PT, Hoek TL, Hickey RW. Advancement Life support Task Force of the International Liaison committee on R: Therapeutic hypothermia after cardiac arrest. An advisory statement by the Advancement Life support Task Force of the International Liaison committee on Resuscitation. Resuscitation. 2003;57(3):231\u20135.","journal-title":"Resuscitation"},{"issue":"2","key":"4319_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/cc4882","volume":"10","author":"M Sander","year":"2006","unstructured":"Sander M, von Heymann C, Spies C. Implementing the International Liaison Committee on Resuscitation guidelines on hypothermia after cardiac arrest. The German experience: still a long way to go? Crit Care (London, England). 2006;10(2):407.","journal-title":"Crit Care (London, England)"},{"issue":"2","key":"4319_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.resuscitation.2006.06.033","volume":"72","author":"S Wolfrum","year":"2007","unstructured":"Wolfrum S, Radke PW, Pischon T, Willich SN, Schunkert H, Kurowski V. Mild therapeutic hypothermia after cardiac arrest: a nationwide survey on the implementation of the ILCOR guidelines in German intensive care units. Resuscitation. 2007;72(2):207\u201313.","journal-title":"Resuscitation"},{"issue":"8","key":"4319_CR11","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.resuscitation.2012.11.003","volume":"84","author":"M Leary","year":"2013","unstructured":"Leary M, Grossestreuer AV, Iannacone S, Gonzalez M, Shofer FS, Povey C, Wendell G, Archer SE, Gaieski DF, Abella BS. Pyrexia and neurologic outcomes after therapeutic hypothermia for cardiac arrest. Resuscitation. 2013;84(8):1056\u201361.","journal-title":"Resuscitation"},{"issue":"24","key":"4319_CR12","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa1906661","volume":"381","author":"JB Lascarrou","year":"2019","unstructured":"Lascarrou JB, Merdji H, Le Gouge A, Colin G, Grillet G, Girardie P, Coupez E, Dequin PF, Cariou A, Boulain T, et al. Targeted temperature management for cardiac arrest with nonshockable rhythm. N Engl J Med. 2019;381(24):2327\u201337.","journal-title":"N Engl J Med"},{"issue":"13","key":"4319_CR13","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jama.2016.14380","volume":"316","author":"PS Chan","year":"2016","unstructured":"Chan PS, Berg RA, Tang Y, Curtis LH, Spertus JA, American Heart Association\u2019s Get With the Guidelines-Resuscitation Investigators. Association between therapeutic hypothermia and survival after in-hospital cardiac arrest. JAMA. 2016;316(13):1375\u201382.","journal-title":"JAMA"},{"issue":"4","key":"4319_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00063-021-00814-3","volume":"117","author":"F Wanek","year":"2022","unstructured":"Wanek F, Mei\u00dfner S, Nuding S, Hober\u00fcck S, Werdan K, Noutsias M, Ebelt H. Influence of therapeutic temperature management on the clinical course in patients after in-hospital cardiac arrest: a retrospective analysis. Med Klin Intensiv Notfallmedizin. 2022;117(4):297\u2013304.","journal-title":"Med Klin Intensiv Notfallmedizin"},{"issue":"2","key":"4319_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.chest.2022.02.056","volume":"162","author":"A Blanc","year":"2022","unstructured":"Blanc A, Colin G, Cariou A, Merdji H, Grillet G, Girardie P, Coupez E, Dequin PF, Boulain T, Frat JP, et al. Targeted temperature management after in-hospital cardiac arrest: an ancillary analysis of targeted temperature management for cardiac arrest with nonshockable rhythm trial data. Chest. 2022;162(2):356\u201366.","journal-title":"Chest"},{"issue":"10265","key":"4319_CR16","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0140-6736(20)32338-2","volume":"396","author":"D Yannopoulos","year":"2020","unstructured":"Yannopoulos D, Bartos J, Raveendran G, Walser E, Connett J, Murray TA, Collins G, Zhang L, Kalra R, Kosmopoulos M, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396(10265):1807\u201316.","journal-title":"Lancet"},{"issue":"8","key":"4319_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2022.1025","volume":"327","author":"J Belohlavek","year":"2022","unstructured":"Belohlavek J, Smalcova J, Rob D, Franek O, Smid O, Pokorna M, Hor\u00e1k J, Mrazek V, Kovarnik T, Zemanek D, et al. Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest: a randomized clinical trial. JAMA. 2022;327(8):737\u201347.","journal-title":"JAMA"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04319-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04319-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04319-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T11:06:03Z","timestamp":1674471963000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04319-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4319"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04319-7","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"12 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local clinical institutional review board and complies with the Declaration of Helsinki. This study was approved by the local ethics committee (2022-300183-WF).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KR, SW, MP, GS and UJ declare that they have no competing interests. GM received lecture honoraria from Getinge and Orion Pharma. SK received research support from Cytosorbents and Daiichi Sankyo. He also received lecture fees from ADVITOS, Biotest, Daiichi Sankyo, Fresenius Medical Care, Gilead, Mitsubishi Tanabe Pharma, MSD, Pfizer and Zoll. He received consultant fees from Fresenius, Gilead, MSD and Pfizer.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"35"}}